Reza Mirzaei
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 03, 2026
IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.
Journal: Neuro-oncology advances
Published: July 18, 2025
Niacin produces an inconsistent treatment response in the EAE model of multiple sclerosis.
Journal: Journal of neuroimmunology
Published: April 30, 2024
Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages.
Journal: Stroke and vascular neurology
Published: January 20, 2023
Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor-Initiating Cells.
Journal: Cancer research
Published: September 21, 2022
Microglia-T cell conversations in brain cancer progression.
Journal: Trends in molecular medicine
Published: April 18, 2022
Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mapping.
Journal: Cancer immunology, immunotherapy : CII
Published: January 16, 2022
PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway.
Journal: Science advances
Published: November 05, 2021
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.
Journal: Brain pathology (Zurich, Switzerland)
Published: September 05, 2020
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.
Journal: Neuro-oncology
Published: April 17, 2020
Last Updated: 09/26/2026